112 related articles for article (PubMed ID: 23720301)
1. Trafficking-deficient mutant GABRG2 subunit amount may modify epilepsy phenotype.
Kang JQ; Shen W; Macdonald RL
Ann Neurol; 2013 Oct; 74(4):547-59. PubMed ID: 23720301
[TBL] [Abstract][Full Text] [Related]
2. Differential molecular and behavioural alterations in mouse models of GABRG2 haploinsufficiency versus dominant negative mutations associated with human epilepsy.
Warner TA; Shen W; Huang X; Liu Z; Macdonald RL; Kang JQ
Hum Mol Genet; 2016 Aug; 25(15):3192-3207. PubMed ID: 27340224
[TBL] [Abstract][Full Text] [Related]
3. Synaptic clustering differences due to different GABRB3 mutations cause variable epilepsy syndromes.
Shi YW; Zhang Q; Cai K; Poliquin S; Shen W; Winters N; Yi YH; Wang J; Hu N; Macdonald RL; Liao WP; Kang JQ
Brain; 2019 Oct; 142(10):3028-3044. PubMed ID: 31435640
[TBL] [Abstract][Full Text] [Related]
4. Mice harboring the T316N variant in the GABA
Jiang YL; Xia L; Zhao JJ; Zhou HM; Mi D; Wang X; Wang YY; Song CG; Jiang W
Exp Neurol; 2024 Jun; 376():114775. PubMed ID: 38604438
[TBL] [Abstract][Full Text] [Related]
5. Differential inflammation responses determine the variable phenotypes of epilepsy induced by GABRG2 mutations.
Sui J; Zhan L; Ji S; Wu W; Chen Y; Yun F; Liang W; Wang J; Cao M; Shen D; Zhang Q
CNS Neurosci Ther; 2024 Feb; 30(2):e14583. PubMed ID: 38357846
[TBL] [Abstract][Full Text] [Related]
6. Epileptic encephalopathy de novo GABRB mutations impair γ-aminobutyric acid type A receptor function.
Janve VS; Hernandez CC; Verdier KM; Hu N; Macdonald RL
Ann Neurol; 2016 May; 79(5):806-825. PubMed ID: 26950270
[TBL] [Abstract][Full Text] [Related]
7. Three epilepsy-associated GABRG2 missense mutations at the γ+/β- interface disrupt GABAA receptor assembly and trafficking by similar mechanisms but to different extents.
Huang X; Hernandez CC; Hu N; Macdonald RL
Neurobiol Dis; 2014 Aug; 68():167-79. PubMed ID: 24798517
[TBL] [Abstract][Full Text] [Related]
8. GABAA receptor biogenesis is impaired by the γ2 subunit febrile seizure-associated mutation, GABRG2(R177G).
Todd E; Gurba KN; Botzolakis EJ; Stanic AK; Macdonald RL
Neurobiol Dis; 2014 Sep; 69():215-24. PubMed ID: 24874541
[TBL] [Abstract][Full Text] [Related]
9. Association of nonsense mutation in GABRG2 with abnormal trafficking of GABAA receptors in severe epilepsy.
Ishii A; Kanaumi T; Sohda M; Misumi Y; Zhang B; Kakinuma N; Haga Y; Watanabe K; Takeda S; Okada M; Ueno S; Kaneko S; Takashima S; Hirose S
Epilepsy Res; 2014 Mar; 108(3):420-32. PubMed ID: 24480790
[TBL] [Abstract][Full Text] [Related]
10. A novel GABRG2 mutation, p.R136*, in a family with GEFS+ and extended phenotypes.
Johnston AJ; Kang JQ; Shen W; Pickrell WO; Cushion TD; Davies JS; Baer K; Mullins JGL; Hammond CL; Chung SK; Thomas RH; White C; Smith PEM; Macdonald RL; Rees MI
Neurobiol Dis; 2014 Apr; 64():131-141. PubMed ID: 24407264
[TBL] [Abstract][Full Text] [Related]
11. GABRA1 and STXBP1: novel genetic causes of Dravet syndrome.
Carvill GL; Weckhuysen S; McMahon JM; Hartmann C; Møller RS; Hjalgrim H; Cook J; Geraghty E; O'Roak BJ; Petrou S; Clarke A; Gill D; Sadleir LG; Muhle H; von Spiczak S; Nikanorova M; Hodgson BL; Gazina EV; Suls A; Shendure J; Dibbens LM; De Jonghe P; Helbig I; Berkovic SF; Scheffer IE; Mefford HC
Neurology; 2014 Apr; 82(14):1245-53. PubMed ID: 24623842
[TBL] [Abstract][Full Text] [Related]
12. The human epilepsy mutation GABRG2(Q390X) causes chronic subunit accumulation and neurodegeneration.
Kang JQ; Shen W; Zhou C; Xu D; Macdonald RL
Nat Neurosci; 2015 Jul; 18(7):988-96. PubMed ID: 26005849
[TBL] [Abstract][Full Text] [Related]
13. Mutant GABA(A) receptor subunits in genetic (idiopathic) epilepsy.
Hirose S
Prog Brain Res; 2014; 213():55-85. PubMed ID: 25194483
[TBL] [Abstract][Full Text] [Related]
14. Modulating Endoplasmic Reticulum Chaperones and Mutant Protein Degradation in GABRG2(Q390X) Associated with Genetic Epilepsy with Febrile Seizures Plus and Dravet Syndrome.
Poliquin S; Nwosu G; Randhave K; Shen W; Flamm C; Kang JQ
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731820
[TBL] [Abstract][Full Text] [Related]
15. Channelopathies in epilepsy: an overview of clinical presentations, pathogenic mechanisms, and therapeutic insights.
Ng AC; Chahine M; Scantlebury MH; Appendino JP
J Neurol; 2024 Jun; 271(6):3063-3094. PubMed ID: 38607431
[TBL] [Abstract][Full Text] [Related]
16. Epilepsy plus blindness in microdeletion of GABRA1 and GABRG2 in mouse and human.
Zhang Q; Forster-Gibson C; Bercovici E; Bernardo A; Ding F; Shen W; Langer K; Rex T; Kang JQ
Exp Neurol; 2023 Nov; 369():114537. PubMed ID: 37703949
[TBL] [Abstract][Full Text] [Related]
17. 4-Phenylbutyrate restored γ-aminobutyric acid uptake and reduced seizures in
Nwosu G; Mermer F; Flamm C; Poliquin S; Shen W; Rigsby K; Kang JQ
Brain Commun; 2022; 4(3):fcac144. PubMed ID: 35911425
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Inhibitory Signaling at the Receptor and Cellular Level; Advances in Our Understanding of GABAergic Neurotransmission and the Mechanisms by Which It Is Disrupted in Epilepsy.
Tipton AE; Russek SJ
Front Synaptic Neurosci; 2022; 14():914374. PubMed ID: 35874848
[TBL] [Abstract][Full Text] [Related]
19. Rare variants in GABRG2 associated with sleep-related hypermotor epilepsy.
Jiang YL; Song CG; Zhou HM; Feng B; Zhao JJ; Liu Y; Man YL; Han J; Liu SB; Jiang W
J Neurol; 2022 Sep; 269(9):4939-4954. PubMed ID: 35486215
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
